Etamiphyllin is a xanthine derivative and methylxanthine bronchodilator primarily investigated for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD), and other bronchospastic… Read more
Etamiphyllin is a xanthine derivative and methylxanthine bronchodilator primarily investigated for the treatment of bronchial asthma, chronic obstructive pulmonary disease (COPD), and other bronchospastic respiratory disorders. This compound functions by inhibiting phosphodiesterase enzymes and antagonizing adenosine receptors to facilitate smooth muscle relaxation in the airways. Laboratories utilize high-quality reference standards of Etamiphyllin, along with its specific impurities and metabolites, to ensure accuracy in analytical testing and method validation. Stable isotope labelled compounds of Etamiphyllin are essential for precise impurity profiling and quantitative analysis in complex matrices, supporting rigorous quality control and stability studies. By providing well-characterized reference materials, researchers and quality control professionals can reliably evaluate the identity, strength, and purity of pharmaceutical formulations, confirming they meet regulatory standards and performance requirements throughout the product lifecycle.